ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cells

Abstract Loss of inflammatory effector function, such as cytokine production and proliferation, is a fundamental driver of failure in T cell therapies against solid tumors. Here, we used CRISPR/Cas9 to genetically disrupt ZFP36, an RNA binding protein that regulates the stability of mRNAs involved i...

Full description

Bibliographic Details
Main Authors: David Mai, Tifara Boyce, Aakash Mehta, Jordan Reff, John Scholler, Neil C. Sheppard, Carl H. June
Format: Article
Language:English
Published: Nature Portfolio 2024-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-53769-8